Cystic fibrosis: understanding a complex disease

E-Communication Session
Chairs: F. Ratjen (Toronto, Canada), H. Spencer (London, United Kingdom)

Role of S-nitrosoglutathione and hypothermia in regulation of mutant δF508 CFTR expression in airway epithelial cells K. Zaman, N. Marozkina, S. Yemen, B. Gaston (Charlottesville, United States Of America)
Lack of therapeutic potential for topical metformin in treatment of airway secretion dehydration in cystic fibrosis Z. Sarah, B. Sansom, E. H. Baker (London, United Kingdom)
The cytokine interleukin-17 is raised in the airway of people with cystic fibrosis M. Brodlie, M. McKean, G. Johnson, A. Fisher, P. Corris, C. Ward, J. Lordan (Newcastle upon Tyne, United Kingdom)
Exercise capacity and pulmonary artery pressure in adults with cystic fibrosis K. Manika, B. Tsaoussis, G. Pitsiou, I. Stanopoulos, I. Kioumis (Thessaloniki, Greece)
Magnetic-resonance-imaging (MRI) for assessment of regional therapy response in patients with cystic fibrosis (CF) M. Eichinger, J. Haeselbarth, A. Niemann, H. U. Kauczor, M. Mall, M. Puderbach (Heidelberg, Germany)
Delivery efficiency of electronic and jet nebulisers aerosolising a colistimethate sodium solution E. Bitterle, M. Tservistas, A. Luithlen, K. Reul, M. Uhlig, O. Denk, M. Keller (Munich, Germany)
Construct validity of the CFq-r in a national us database A. Quittner, J. Wagener, G. Sawicki, D. Pasta, A. McMullen, L. Rasouliyan (Coral Gables, Aurora, Boston, San Francisco, Rochester, United States Of America)
Cystic fibrosis questionnaire reference data in a healthy, Dutch population 6-20 yrs C. Sintnicolaas, J. Vercoulen, J. Peters, J. Yntema (Nijmegen, Netherlands)
Transforming growth factor β in induced sputum and whole blood in cystic fibrosis S. Schmitt-Grohé, L. van den Boom, D. N‘Gampolo, O. Eickmeier, R. Schubert, S. Zielen, B. Zur, M. J. Lentze (Bonn, Frankfurt, Germany)
The activity of selected proteolytic enzymes in saliva of cystic fibrosis patients L. Minarowski, A. Minarowska, D. Sands, M. Knas, S. Szajda, A. Karwowska, M. Gacko (Bialystok, Warsaw, Poland)
Long term follow up of the lung function in cystic fibrosis patients with allergic bronchopulmonary aspergillosis (ABPA) F. Brinkmann, S. Junge, U. Hildebrandt, M. Ballmann (Hanover, Germany)
Comparison of induced sputum samples, versus BAL samples in detection of the microbial load among children with cystic fibrosis C. Lilos, E. Hatziagorou, F. Kirvassilis, M. Ventouri, A. Zambouri, M. Mylona, D. Sofianou, J. Tsanakas (Thessaloniki, Greece)
Evidence for local IgE production to Aspergillus fumigatus in children with cystic fibrosis T. Eiwegger, M. Gona, P. Fucik, A. Glaser, F. Horak, E. Nachbaur, S. Renner, S. Gruber, R. Crameri, Z. Szepfalusi, T. Frischer (Vienna, Austria; Davos, Switzerland)
Analysis of exhaled breath and its value in prediction of exacerbations in children suffering from CF J. van Berkel, C. Robroeks, J. Dallinga, Q. Jobsis, E. Moonen, E. Wouters, E. Dompeling, F. J. van Schooten (Maastricht, Horn, Netherlands)
In vivo evidence for aspergillus fumigatus and pseudomonas aeruginosa driven th-17 type inflammatory responses in the lungs of CF-patients T. Eiwegger, M. Gona, P. Fucick, A. Glaser, F. Horak, E. Nachbaur, S. Renner, S. Gruber, R. Crameri, Z. Szepfalusi, T. Frischer (Vienna, Davos, Austria)
Effects of duramycin on cardiac voltage-gated ion channels M. Freissmuth, X. Koenig, C. Gloeckel (Vienna, Austria)
The impact of Achromobacter xylosoxidans on lung function and hospital admissions in adult patients with cystic fibrosis (CF) S. Cowman, D. Bilton, K. Gyi, K. Alshafi, W. Banya, M. Hodson (London, United Kingdom)
Lung function decline and variability in end stage cystic fibrosis G. Jifon, A. Ponnuswamy, S. Ashiq, J. F. Greenwood, M. Ledson, M. Walshaw (Liverpool, United Kingdom)
Metabolomic analysis by nuclear magnetic resonance spectroscopy of exhaled breath condensate in patients with cystic fibrosis P. Montuschi, D. Paris, D. Melck, V. Lucidi, A. Motta (Rome, Pozzuoli (Naples), Italy)
Peripheral muscle strength and exercise capacity in children with cystic fibrosis and non-cystic fibrosis bronchiectasis B. U. Tugay, H. Arikan, U. Ozcelik, N. Tugay (Mugla, Ankara, Turkey)